Advancements and New Treatment Options: Optimizing Care for Patients with Graft-vs-Host Disease : Episode 3
Opinion
Video
Role of Biomarkers in Graft-vs-Host Disease
Corey Cutler, MD, MPH, discusses the role of prognostic markers in graft-vs-host disease and how they can potentially inform treatment selection.
EP: 1.Overview of Graft-vs-Host Disease (GvHD)
EP: 2.How Does GvHD Typically Present?
Now Viewing
EP: 3.Role of Biomarkers in Graft-vs-Host Disease
EP: 4.Staging Practices for Chronic Graft-vs-Host Disease
EP: 5.First-Line Therapy for Chronic GvHD
EP: 6.Treating Patients With Steroid-Refractory Chronic GvHD
EP: 7.Approved Therapies for Steroid-Refractory Chronic GvHD
EP: 8.Therapies in Development for Chronic GvHD
EP: 9.Supportive Care and Medication Access in GvHD
Related Videos
Related Content
%201%20(1)-Recovered%20copy.jpg?fit=crop&auto=format)
%201%20(1)-Recovered%20copy.jpg?fit=crop&auto=format)
